LondonThe blockbuster Alzheimer’s drugs target the wrong signal.
sTREM2 marks microglia and YKL-40 marks astrocytes; both track tau pathology, and their signal weakens as disease advances.
The authors call the weakening “glial exhaustion,” but caution the finding is association, not proof of causation.
Sources: Nature